PE20010580A1 - Composicion farmaceutica para tratar la diabetes - Google Patents
Composicion farmaceutica para tratar la diabetesInfo
- Publication number
- PE20010580A1 PE20010580A1 PE2000000887A PE0008872000A PE20010580A1 PE 20010580 A1 PE20010580 A1 PE 20010580A1 PE 2000000887 A PE2000000887 A PE 2000000887A PE 0008872000 A PE0008872000 A PE 0008872000A PE 20010580 A1 PE20010580 A1 PE 20010580A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alcoxycarbonyl
- carboxyl
- pharmaceutical composition
- ora
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25044399 | 1999-09-03 | ||
JP2000056021 | 2000-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010580A1 true PE20010580A1 (es) | 2001-05-25 |
Family
ID=26539777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000887A PE20010580A1 (es) | 1999-09-03 | 2000-08-29 | Composicion farmaceutica para tratar la diabetes |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1212090A2 (ko) |
KR (1) | KR20020063555A (ko) |
CN (1) | CN1372476A (ko) |
AR (1) | AR031674A1 (ko) |
AU (1) | AU6868000A (ko) |
CA (1) | CA2383946A1 (ko) |
CO (1) | CO5180632A1 (ko) |
HK (1) | HK1044711A1 (ko) |
HU (1) | HUP0203285A3 (ko) |
NO (1) | NO20021036L (ko) |
PE (1) | PE20010580A1 (ko) |
PL (1) | PL354295A1 (ko) |
RU (1) | RU2002108346A (ko) |
WO (1) | WO2001017513A2 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051441A1 (fr) * | 2000-12-26 | 2002-07-04 | Sankyo Company, Limited | Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline |
WO2002080936A1 (en) | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
DE60233655D1 (de) | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R und retinoid x rezeptorenmodulatoren |
FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
CA2488699A1 (en) * | 2002-06-12 | 2003-12-24 | Sumitomo Pharmaceuticals Co., Ltd. | Indole, indazole, and benzazole derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04501722A (ja) * | 1988-11-14 | 1992-03-26 | ジ・アップジョン・カンパニー | 抗―糖尿病、抗―肥満症および抗―アテローム性動脈硬化症薬として有用なα―アミノ―インドール―3―酢酸 |
AU651571B2 (en) * | 1990-02-09 | 1994-07-28 | Pharmacia & Upjohn Company | Use of insulin sensitizing agents to treat hypertension |
DK0801059T3 (da) * | 1994-11-29 | 2001-09-24 | Dainippon Pharmaceutical Co | Indolderivat |
-
2000
- 2000-08-29 PE PE2000000887A patent/PE20010580A1/es not_active Application Discontinuation
- 2000-08-30 AR ARP000104514A patent/AR031674A1/es not_active Application Discontinuation
- 2000-09-01 PL PL00354295A patent/PL354295A1/xx not_active Application Discontinuation
- 2000-09-01 KR KR1020027002851A patent/KR20020063555A/ko not_active Application Discontinuation
- 2000-09-01 AU AU68680/00A patent/AU6868000A/en not_active Abandoned
- 2000-09-01 HU HU0203285A patent/HUP0203285A3/hu unknown
- 2000-09-01 RU RU2002108346/14A patent/RU2002108346A/ru not_active Application Discontinuation
- 2000-09-01 CO CO00065981A patent/CO5180632A1/es not_active Application Discontinuation
- 2000-09-01 CN CN00812420A patent/CN1372476A/zh active Pending
- 2000-09-01 WO PCT/JP2000/005951 patent/WO2001017513A2/en not_active Application Discontinuation
- 2000-09-01 CA CA002383946A patent/CA2383946A1/en not_active Abandoned
- 2000-09-01 EP EP00956872A patent/EP1212090A2/en not_active Withdrawn
-
2002
- 2002-03-01 NO NO20021036A patent/NO20021036L/no not_active Application Discontinuation
- 2002-08-15 HK HK02105969.4A patent/HK1044711A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20021036D0 (no) | 2002-03-01 |
KR20020063555A (ko) | 2002-08-03 |
WO2001017513A3 (en) | 2001-09-20 |
EP1212090A2 (en) | 2002-06-12 |
AU6868000A (en) | 2001-04-10 |
HK1044711A1 (zh) | 2002-11-01 |
WO2001017513A2 (en) | 2001-03-15 |
AR031674A1 (es) | 2003-10-01 |
CA2383946A1 (en) | 2001-03-15 |
NO20021036L (no) | 2002-04-26 |
HUP0203285A3 (en) | 2003-02-28 |
PL354295A1 (en) | 2004-01-12 |
CO5180632A1 (es) | 2002-07-30 |
RU2002108346A (ru) | 2003-11-20 |
CN1372476A (zh) | 2002-10-02 |
HUP0203285A2 (hu) | 2003-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2312106C2 (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
KR950702982A (ko) | 치환된 티아졸리딘디온 유도체(Substituted Thiazolidinedione Derivatives) | |
PE20001483A1 (es) | Acidos oxamicos y derivados como ligandos de receptores tiroideos | |
RU2003137825A (ru) | Пираноиндазолы и их использование при лечении глаукомы | |
LU91926I2 (fr) | Belimumab et ses dérivés pharmaceutiquement acceptables (Benlysta®) | |
KR880002834A (ko) | α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도 | |
EA200300323A1 (ru) | ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ) | |
BR0009864A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto | |
UY24543A1 (es) | Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol- 3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona | |
DE69530094D1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
ATE420090T1 (de) | Chemokine-rezeptor-antagonisten und methoden zu deren anwendung | |
CY1107500T1 (el) | Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ | |
KR930702287A (ko) | 신규화합물 | |
CO5440230A1 (es) | Nuevo compuesto heterociclico que comprende tetrahidroisoquinolina y una sal farmaceuticamente aceptable del mismo | |
PE20010580A1 (es) | Composicion farmaceutica para tratar la diabetes | |
RU2008126389A (ru) | Производные 1,1- диоксотиоморфолинилиндолилметанона для применения в качестве модуляторов гистаминаз(н3) | |
AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
KR960700696A (ko) | 정맥성 질환 치료에 유용한 5-하이드록시트립타민-2 수용체 길항물질 조성물(5-ht₂receptor antagonist compositions useful in treating venous conditions) | |
DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
NZ513922A (en) | Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione | |
KR900700098A (ko) | 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체 | |
DE50312523D1 (de) | Pharmazeutische wirkstoffkombination sowie deren verwendung | |
KR880007462A (ko) | 빈뇨치료용 프로피오페논 유도체 | |
KR910007911A (ko) | 벤조사이클로알킬아미노피리딘아민 및 관련 화합물, 이들의 제조방법 및 중간체 및 약제로서의 이들의 용도 | |
RU2005141559A (ru) | Способ лечения и предотвращения симптомов нижнего отдела мочевых путей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |